ImmunoPrecise Antibodies Ltd. added Jennifer Bath to its board, months after she became the company's president and CEO.
The Canadian clinical research organization also appointed Charles Wheelock as its global chief technology officer.
Wheelock has spent 16 years at Microsoft in various roles, most recently as a senior global technical account manager.
